home / stock / mrna / mrna news


MRNA News and Press, Moderna Inc. From 03/04/26

Stock Information

Company Name: Moderna Inc.
Stock Symbol: MRNA
Market: NASDAQ
Website: modernatx.com

Menu

MRNA MRNA Quote MRNA Short MRNA News MRNA Articles MRNA Message Board
Get MRNA Alerts

News, Short Squeeze, Breakout and More Instantly...

MRNA - Stock index futures muted ahead of labor report, eyes on Middle East tensions

2026-03-04 04:52:43 ET More on markets Shocks Are Part Of Life; Sentiment Coming Into Them Matters Dow Jones And U.S. Index Outlook: Stocks Get Caught In The Crossfire 2 Lines Are Being Crossed In Iran: Why Oil Could Hit $200+ A Barrel Dow futures plunge 500+...

MRNA - MRNA Price Target Alert: $37.00. Issued by Jefferies

2026-03-03 19:03:32 ET Andrew Tsai from Jefferies issued a price target of $37.00 for MRNA on 2026-03-03 22:15:00. The adjusted price target was set to $37.00. At the time of the announcement, MRNA was trading at $49.83. The overall price target consensus is at $34.89 wi...

MRNA - Hold Recommendation Issued On MRNA By Jefferies

2026-03-03 18:15:03 ET Jefferies analyst issues HOLD recommendation for MRNA on March 3, 2026 10:15PM ET. The previous analyst recommendation was Hold. MRNA was trading at $49.83 at issue of the analyst recommendation. The overall analyst consensus : HOLD. Current an...

MRNA - Moderna surges after hours on patent settlement with Arbutus and Genevant

2026-03-03 17:16:52 ET More on Moderna Moderna, Inc. (MRNA) Presents at TD Cowen 46th Annual Health Care Conference Transcript Moderna, Inc. (MRNA) Q4 2025 Earnings Call Transcript Moderna, Inc. 2025 Q4 - Results - Earnings Call Presentation EMA recommends au...

MRNA - Moderna, Inc. (MRNA) Presents at TD Cowen 46th Annual Health Care Conference Transcript

2026-03-03 16:22:12 ET Moderna, Inc. (MRNA) TD Cowen 46th Annual Health Care Conference March 3, 2026 1:50 PM EST... Read the full article on Seeking Alpha For further details see: Moderna, Inc. (MRNA) Presents at TD Cowen 46th Annual Health Care Conference Transcript

MRNA - Moderna Resolves Global Patent Litigation with Arbutus/Genevant

Moderna to pay $950 million with no future royalties to resolve all global litigation; corresponding charge expected in Q1 2026 District Court's Section 1498 decision to be appealed to the Federal Circuit Court of Appeals with potential additional payment contingent on the outcome; no accrua...

MRNA - Top 10 Healthcare Stocks of February

2026-03-02 15:31:35 ET More on healthcare stocks Sector Rotation: Healthcare XLV Should Be The Next Stop ImmunityBio: Disconnect Between Clinical Progress And Stock Performance VT: Still The Best Approach To Passive Investing Notable healthcare headlines for ...

MRNA - AAPL, AA, BKR, and AMGN are among the top stocks for momentum, says Oppenheimer

2026-03-02 13:04:23 ET More on the markets The Next Bust Could Be On The Horizon Cross-Asset Vols Spike On Iran Risk As Oil Surges SPY: The Market Has Entered A Wait-And-See Phase Stocks make a U-turn into the green amid U.S.-Israel-Iran conflict escalation ...

MRNA - Notable healthcare headlines for the week: Viatris, Novo Nordisk, and Gilead Sciences in focus

2026-03-01 09:05:41 ET More on State Street Health Care Select Sector SPDR ETF Sector Rotation: Healthcare XLV Should Be The Next Stop VT: Still The Best Approach To Passive Investing Market Sector Review: Extreme Market Bifurcation Notable healthcare headlin...

MRNA - EMA recommends authorization of Moderna combination COVID/flu vaccine

2026-02-27 09:27:55 ET More on Moderna Moderna, Inc. (MRNA) Q4 2025 Earnings Call Transcript Moderna, Inc. 2025 Q4 - Results - Earnings Call Presentation Moderna: FDA RTF Derails mRNA-1010 And Reignites The Sell Case CDC advisory meeting in March to focus on ...

Previous 10 Next 10